FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced receipt of the FDA’s Emergency Use Authorization (“EUA”) for the BD Veritor At-Home COVID-19 Test. The test is an ...
BD VERITOR SYSTEM FOR RAPID DETECTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) reader by BD Diagnostics BD Diagnostics announced that it has received clearance and CLIA waiver from the FDA for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results